Abstract
Receptor-mediated tumor targeting has received major attention in the field of cancer drug delivery in the past few years. Receptors, as molecular target has opened new opportunities for cellular or intracellular targeting of drug loaded delivery systems conjugated with targeting moieties i.e. ligand. This receptor mediated targeting of cancer drug through nano carrier systems to cancerous tissue offer protection and improves the pharmacokinetics of various drugs and help to overcome the systemic toxicity and adverse effects that result from the non-selective nature of most current cancer therapeutic agents. The article reviews the scope of receptor mediated targeting of anticancer drug loaded in various nanocarriers and also summarize recent perspective and challenges in the field of nanocarrier-aided drug delivery and drug targeting for cancer therapy.
Keywords: Receptor, ligand, nanocarrier, tumor targeting, vascular endothelial growth factor, basic fibroblast growth factor, diapedesis, enhanced permeability and retention, prostate-specific membrane antigens, lysosomes, transferrin receptor, apotransferrin, ferrotransferrin, Tf-coupled poly(ethylene glycol), PEG stealth liposomes, Artemisinin, folate receptor, docetaxel, polymer arabinogalactan, methotrexate, transforming growth factor-, amphiregulin, betacellulin, heparin-binding EGF, glycerol monooleate coated magnetic nanoparticles, boron neutron capture therapy, Bevacizumab, doxorubicin, Isoaspartate-glycine-arginine, doxorubicin-loaded immunoliposomes, Intercellular cell adhesion molecule-1, Prostate specific membrane antigen
Current Drug Delivery
Title: Receptor Mediated Tumor Targeting: An Emerging Approach for Cancer Therapy
Volume: 8 Issue: 1
Author(s): Chandana Mohanty, Manasi Das, Jagat R. Kanwar and Sanjeeb K. Sahoo
Affiliation:
Keywords: Receptor, ligand, nanocarrier, tumor targeting, vascular endothelial growth factor, basic fibroblast growth factor, diapedesis, enhanced permeability and retention, prostate-specific membrane antigens, lysosomes, transferrin receptor, apotransferrin, ferrotransferrin, Tf-coupled poly(ethylene glycol), PEG stealth liposomes, Artemisinin, folate receptor, docetaxel, polymer arabinogalactan, methotrexate, transforming growth factor-, amphiregulin, betacellulin, heparin-binding EGF, glycerol monooleate coated magnetic nanoparticles, boron neutron capture therapy, Bevacizumab, doxorubicin, Isoaspartate-glycine-arginine, doxorubicin-loaded immunoliposomes, Intercellular cell adhesion molecule-1, Prostate specific membrane antigen
Abstract: Receptor-mediated tumor targeting has received major attention in the field of cancer drug delivery in the past few years. Receptors, as molecular target has opened new opportunities for cellular or intracellular targeting of drug loaded delivery systems conjugated with targeting moieties i.e. ligand. This receptor mediated targeting of cancer drug through nano carrier systems to cancerous tissue offer protection and improves the pharmacokinetics of various drugs and help to overcome the systemic toxicity and adverse effects that result from the non-selective nature of most current cancer therapeutic agents. The article reviews the scope of receptor mediated targeting of anticancer drug loaded in various nanocarriers and also summarize recent perspective and challenges in the field of nanocarrier-aided drug delivery and drug targeting for cancer therapy.
Export Options
About this article
Cite this article as:
Mohanty Chandana, Das Manasi, R. Kanwar Jagat and K. Sahoo Sanjeeb, Receptor Mediated Tumor Targeting: An Emerging Approach for Cancer Therapy, Current Drug Delivery 2011; 8 (1) . https://dx.doi.org/10.2174/156720111793663606
DOI https://dx.doi.org/10.2174/156720111793663606 |
Print ISSN 1567-2018 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5704 |
Call for Papers in Thematic Issues
Advancements in Robotic and AI-based Drug Discovery and Delivery for Neurological Disorders
Neurological disorders, including Alzheimer's disease, Parkinson's disease, epilepsy, and brain tumors, pose significant challenges in drug delivery due to the blood-brain barrier's intricate structure and the complexity of neuronal networks. Traditional drug delivery methods often fall short in reaching therapeutic concentrations within the central nervous system, limiting treatment efficacy and ...read more
Electrospun Fibers as Drug Delivery Systems
In recent years, electrospun fibers have attracted considerable attention as potential platforms for drug delivery due to their distinctive properties and adaptability. These fibers feature a notable surface area-to-volume ratio and can be intentionally designed with high porosity, facilitating an increased capacity for drug loading and rendering them suitable for ...read more
Emerging Nanotherapeutics for Mitigation of Neurodegenerative Disorders
Conditions affecting the central nervous system (CNS) present a significant hurdle due to limited access of both treatments and diagnostic tools for the brain. The blood-brain barrier (BBB) acts as a barrier, restricting the passage of molecules from the bloodstream into the brain. The most formidable challenge facing scientists is ...read more
Nanoemulsions in cancer therapy
Solid tumors are characterized by leaky vascular structure, defective angiogenesis and high interstitial fluid load, providing opportunities for nanoparticles to preferentially exudate and be retained in tumors. This phenomenon is commonly referred to as the enhanced permeability and retention (EPR) effect, which is considered to be an important reason why ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Emerging Potential of Citrus Flavanones as an Antioxidant in Diabetes and its Complications
Current Topics in Medicinal Chemistry Chemokine Receptor CCR5 Antagonist Maraviroc: Medicinal Chemistry and Clinical Applications
Current Topics in Medicinal Chemistry Death-Associated Protein Kinase 1 as a Promising Drug Target in Cancer and Alzheimer’s Disease
Recent Patents on Anti-Cancer Drug Discovery Mesenchymal Stem Cell Therapy for Patients with Ischemic Heart Failure- Past, Present, and Future
Current Stem Cell Research & Therapy Incremental Value of Two Dimensional Speckle Tracking Echocardiography in the Functional Assessment and Characterization of Subclinical Left Ventricular Dysfunction
Current Cardiology Reviews Molecule of the Month
Current Topics in Medicinal Chemistry Current Clinical Applications of In Vivo Magnetic Resonance Spectroscopy and Spectroscopic Imaging
Current Medical Imaging The Role of TRIM Proteins in Vascular Disease
Current Vascular Pharmacology Common Genetic Conditions of Ischemic Stroke to Keep in Mind
Current Molecular Medicine Therapeutic Potential of Stem/Progenitor Cells in Human Skeletal Muscle for Cardiovascular Regeneration
Current Stem Cell Research & Therapy Calcium Channel Blockers in Obesity-Related Hypertension
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Common Comorbidities that Alter Heart Failure Prognosis - Shaping New Thinking for Practice
Current Cardiology Reviews Cardiovascular Manifestations of COVID-19
Current Cardiology Reviews The Potential of Natural Products in the Management of Cardiovascular Disease
Current Pharmaceutical Design Oxidative Stress and Endothelial Dysfunction in Cardiovascular Disease: Mitochondria-Targeted Therapeutics
Current Medicinal Chemistry Mineralocorticoid Receptor Antagonism and Cardiac Remodeling in Ischemic Heart Failure
Current Medicinal Chemistry - Cardiovascular & Hematological Agents Echocardiogram versus Cardiac Magnetic Resonance Imaging for the Diagnosis of Non-compaction Cardiomyopathy – A Case Report
New Emirates Medical Journal Phospholipase A2 is an Inflammatory Predictor in Cardiovascular Diseases: Is there any Spacious Room to Prove the Causation?
Current Cardiology Reviews Defensive and Offensive Cross-Reactive Antibodies Elicited by Pathogens: The Good, the Bad and the Ugly
Current Medicinal Chemistry Impact of Breaking up of Sitting Time on Anti-inflammatory Response Induced by Extracellular Vesicles
Current Pharmaceutical Design